﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>14</Volume>
      <Issue>4</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2025</Year>
        <Month>10</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Antihypertensive efficacy of allopurinol; a mini-review on current concepts</ArticleTitle>
    <FirstPage>e27587</FirstPage>
    <LastPage>e27587</LastPage>
    <ELocationID EIdType="doi">10.34172/jnp.2025.27587</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ali Thoulfikar A.</FirstName>
        <LastName>Imeer</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-0842-1072</Identifier>
      </Author>
      <Author>
        <FirstName>Abdul Amir H.</FirstName>
        <LastName>Kadhum</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0003-4074-9123</Identifier>
      </Author>
      <Author>
        <FirstName>Qais R.</FirstName>
        <LastName>Lahhob</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-5259-8946</Identifier>
      </Author>
      <Author>
        <FirstName>Hussein Ali</FirstName>
        <LastName>Al-Bahrani</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9637-3359</Identifier>
      </Author>
      <Author>
        <FirstName>Maytham Ahmed</FirstName>
        <LastName>Abdul Aemah</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-3333-9778</Identifier>
      </Author>
      <Author>
        <FirstName>Omer Mansib</FirstName>
        <LastName>Kassid</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6459-0773</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jnp.2025.27587</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>10</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>01</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <Abstract>Allopurinol, primarily used to treat gout, has shown potential as an antihypertensive agent due to its effects on oxidative stress and endothelial function. This agent is not typically used as a first-line treatment for hypertension; however, some studies have suggested that it may have potential antihypertensive effects. More research is needed to establish its efficacy and mechanisms in treating hypertension.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Allopurinol</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hypertension</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Hyperuricemia</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Oxidative stress</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Blood pressure</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>